We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s experiment in whether it can publish the clinical trials data behind drug approvals attracted a lone volunteer and now the agency is seeking public comment on whether they should stick with the project or try something else. Read More
A key Senate committee on Wednesday approved a package of health pricing legislation over the objections of generics makers and pharmacy benefits managers. Read More
The proposed rule would remove safe harbor protection under the Anti-Kickback Statute for manufacturer rebates to pharmacy benefit managers, Part D plans and Medicaid managed care organizations. Read More
Sanofi will hand over its business applications to Google’s cloud platform, which the companies hope will speed up the drugmakers’ operations. Read More
Forty-eight states were involved in a price-fixing investigation that has now led to multi-state and multimillion-dollar litigation against some of the largest generics makers, a newly revealed complaint shows. Read More
Acting FDA Commissioner Ned Sharpless issued another warning to violative stem cell manufacturers following a judge’s permanent injunction against two Florida clinics on Tuesday, promising that the agency’s “aggressive oversight” will continue. Read More
A bipartisan group of U.S. lawmakers introduced a bill aimed at increasing the availability of over-the-counter medications to help bring down healthcare costs. Read More
AbbVie sent shockwaves through the drug industry Tuesday, announcing that it had reached a deal to acquire fellow drug giant Allergan for approximately $63 billion. Read More